Literature DB >> 19491612

Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.

Manami Inoue1, Mitsuhiko Noda, Norie Kurahashi, Motoki Iwasaki, Shizuka Sasazuki, Hiroyasu Iso, Shoichiro Tsugane.   

Abstract

The impact of metabolic factors, which are major risk factors for cardiovascular disease, on total cancer risk has not been clarified. We prospectively examined whether metabolic factors and their aggregates predict the subsequent occurrence of total and major sites of cancer in the Japan Public Health Center-based Prospective Study. A total of 27 724 participants (9548 men and 18 176 women) aged 40-69 years participating in a questionnaire and health checkup survey in 1993-1995 were followed for total cancer incidence through 2004. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated for metabolic factors and for two criteria of their aggregates (three or more than three factors and two or more than two additional factors in addition to being overweight) with a Cox proportional hazards model to control for potential confounding factors. In both sexes, the presence of metabolic factors in the aggregate did not predict subsequent occurrence of cancer as a whole. By site, a significant increase in risk was observed for male liver cancer [HR = 1.73, CI = 1.03-2.91 (three or more than three factors); HR = 1.99, CI = 1.11-3.58 (two or more than two additional factors in addition to being overweight)], and female pancreatic cancer [HR = 1.99, CI = 1.00-3.96 (two or more than two additional factors in addition to being overweight)]. For other sites, positive associations were observed only for specific metabolic factors, that is, high triglycerides and male colon cancer (HR = 1.71, CI = 1.11-2.62), and obesity and female breast cancer (HR = 1.75, CI = 1.21-2.55). Metabolic factors in the aggregate may have little impact on total cancer risk in the Japanese population, although the association between specific components and specific cancers suggests an etiologic link between them.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491612     DOI: 10.1097/CEJ.0b013e3283240460

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  52 in total

1.  Metabolic syndrome is associated with increased prevalence of advanced colorectal polyps.

Authors:  S Tal; E Melzer; T Chsherbakov; S Malnick
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

Review 2.  The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Suhag Patel; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2014-02       Impact factor: 3.062

3.  Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans.

Authors:  Anna H Wu; Cheryl Vigen; Lesley M Butler; Chiu-Chen Tseng
Journal:  Int J Cancer       Date:  2017-09-06       Impact factor: 7.396

Review 4.  Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Concetta Rafaniello; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

5.  A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women.

Authors:  Geoffrey C Kabat; Mimi Y Kim; Ulrike Peters; Marcia Stefanick; Lifang Hou; Jean Wactawski-Wende; Catherine Messina; James M Shikany; Thomas E Rohan
Journal:  Eur J Cancer Prev       Date:  2012-07       Impact factor: 2.497

Review 6.  Meta-analysis of metabolic syndrome and prostate cancer.

Authors:  M Gacci; G I Russo; C De Nunzio; A Sebastianelli; M Salvi; L Vignozzi; A Tubaro; G Morgia; S Serni
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-02-21       Impact factor: 5.554

Review 7.  The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Prateek Lohia; Chetna Jinjuvadia; Sergio Montoya; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2013-01       Impact factor: 3.062

Review 8.  Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.

Authors:  K Esposito; P Chiodini; A Capuano; G Bellastella; M I Maiorino; E Parretta; A Lenzi; D Giugliano
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

9.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

10.  Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.

Authors:  Hee Jin Kim; Nayoung Kim; Hyun Young Kim; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Kyoung-Ho Lee; Young-Hoon Kim; Hee Man Kim; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2014-09-21       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.